T 2214/14 (New onset diabetes/UNIVERSITY OF PITTSBURGH) of 08.09.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T221414.20200908
- Date of decision
- 8 September 2020
- Case number
- T 2214/14
- Online on
- 15 September 2020
- Petition for review of
- -
- Application number
- 07813820.3
- IPC class
- C12N 15/11
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- MICROSPHERE-BASED COMPOSITION FOR PREVENTING AND/OR REVERSING NEW-ONSET AUTOIMMUNE DIABETES
- Applicant name
- Baxter International Inc.
Baxter Healthcare S.A.
University of Pittsburgh - Of the Commonwealth
System of Higher Education - Opponent name
- -
- Board
- 3.3.08
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 54 (2007)European Patent Convention Art 56 (2007)European Patent Convention Art 83 (2007)European Patent Convention Art 84 (2007)European Patent Convention Art 123(2) (2007)
- Keywords
- Main request - requirements of the EPC met
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The case is remitted to the examining division with the order to grant a patent based on claims 1 to 8 according to the main request filed on 13 September 2019, and a description to be adapted thereto.